Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Age: 18 years and over

Healthy Volunteers:

This study is NOT accepting healthy volunteers

Inclusion Criteria:

* 18 years of age or older * Able to speak and read in English * Actively receiving Trastuzumab or an anthracycline-based treatment * Diagnosed with stages 0-III Breast Cancer

Exclusion Criteria:

\- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)

Interventions:

BEHAVIORAL: Cardiovascular Health Education and Gaming through Virtual Reality

Conditions:

Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer, Virtual Reality, Trastuzumab

Keywords:

virtual reality, breast cancer, antracyclines, trastuzumab, VCU, Virginia Commonwealth University

Contact(s): Arnethea Sutton, Ph.D - careslab@vcu.edu

Principal Investigator:

IRB Number:

System ID: NCT07426913

Thank you for choosing StudyFinder. Please visit http://studyfinder.cctr.vcu.edu to find a Study which is right for you and contact ctrrecruit@vcu.edu if you have questions or need assistance.

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Email this study information to me

Contact the study team